Periodontitis deteriorates metabolic control in type 2 diabetic Goto-Kakizaki rats

Journal of Periodontology

Volumn 77, Issue 3, 2006, Pages 350-356

  Pontes Andersen, Carla C ^a   Buschard, Karsten ^b   Flyvbjerg, Allan ^c   Stoltze, Kaj ^a   Holmstrup, Palle ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Animal models; Diabetes; Periodontitis; Rats

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADIPOSE TISSUE; ALVEOLAR BONE; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BONE DESTRUCTION; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES CONTROL; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID BLOOD LEVEL; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC REGULATION; MOLAR TOOTH; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTITIS; RAT; RAT STRAIN; SUPERNATANT; TISSUE LEVEL; TOOTH RADIOGRAPHY; ANIMAL; BLOOD; DISEASE MODEL; LIGATION; METABOLISM; NONPARAMETRIC TEST; WISTAR RAT;

ADIPOSE TISSUE; ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; CYTOKINES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FATTY ACIDS, NONESTERIFIED; GLUCOSE INTOLERANCE; INSULIN; INSULIN RESISTANCE; LIGATION; MALE; PERIODONTITIS; RATS; RATS, INBRED STRAINS; RATS, WISTAR; STATISTICS, NONPARAMETRIC;

EID: 33646366926     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050184     Document Type: Article

References (32)

1. Li X, Kolltveit KM, Tronstad L, Olsen I. Systemic diseases caused by oral infection. Clin Microbiol Rev 2000;13:547-558.
2. Renvert S. Destructive periodontal disease in relation to diabetes mellitus, cardiovascular diseases, osteoporosis and respiratory diseases. Oral Health Prev Dent 2003;1:341-357.
3. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet 2005;365:1333-1346.
4. Hugoson A, Thorstensson H, Falk H, Kuylenstierna J. Periodontal conditions in insulin-dependent diabetics. J Clin Periodontol 1989;16:215-223.
5. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991;62:123-131.
6. Seppala B, Ainamo J. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. J Clin Periodontol 1994;21:161-165.
7. Safkan-Seppala B, Ainamo J. Periodontal conditions in insulin-dependent diabetes mellitus. J Clin Periodontol 1992;19:24-29.
8. Sandberg GE, Sundberg HE, Fjellstrom CA, Wikblad KF. Type 2 diabetes and oral health: A comparison between diabetic and non-diabetic subjects. Diabetes Res Clin Pract 2000;50:27-34.
9. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002;30:182-192.
10. Marugame T, Hayasaki H, Lee K, Eguchi H, Matsumoto S. Alveolar bone loss associated with glucose tolerance in Japanese men. Diabet Med 2003;20: 746-751.
11. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: A two-way relationship. Ann Periodontol 1998;3:51-61.
12. Saito T, Shimazaki Y, Kiyohara Y, et al. The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: The Hisayama study. J Dent Res 2004;83:485-490.
13. Iwamoto Y, Nishimira F, Nakagawa M, et al. The effect of antimicrobial periodontal treatment in circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001;72:774-778.
14. Holzhausen M, Garcia DF, Pepato MT, Marcantonio E Jr. The influence of short-term diabetes mellitus and insulin therapy on alveolar bone loss in rats. J Periodontal Res 2004;39:188-193.
15. Östenson C-G. The Goto-Kakizaki rat. In: Sima AAF, Shafrir E, eds. Animal Models of Diabetes: A Primer. Amsterdam: Hardwood Academic Publisher; 2001: 197-210.
16. Goto Y, Suzuki K-I, Sasaki M, Ono T, Abe S. GK rat as a model for non-obese, non-insulin-dependent diabetes. Selective breeding over 35 generations. In: Shafrir E, Renold AE, eds. Frontiers in Diabetes Research. Lessons From Animal Models II. London: John Libbey & Company; 1988:301-303.
17. Björnsson MJ, Velschow S, Stoltze K, Havemose-Poulsen A, Schou S, Holmstrup P. The influence of diet consistence, drinking water and bedding on periodontal disease in Sprague-Dawley rats. J Periodontal Res 2003;38:543-550.
18. Grauballe MC, Bentzen BH, Björnsson M, et al. The effect of spironolactone on experimental periodontitis in rats. J Periodontal Res 2005;40:212-217.
19. Buhl ES, Jessen N, Pold R, et al. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 2002;51: 2199-2206.
20. Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX. The use of areas under curves in diabetes research. Diabetes Care 1995;18:245-250.
21. Matthews DR, Hosker JP, Rudenski BA, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
22. Kawamura T, Yoshida K, Sugawara A, et al. Impact of exercise and angiotensin converting enzyme inhibition on tumor necrosis factor-α and leptin in fructose-fed hypertensive rats. Hypertens Res 2002;25:919-926.
23. Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 2000;27:537-541.
24. Lepor N. News and reviews from the literature. Rev Cardiovasc Med 2004;5:182-185.
25. Diamond J. The double puzzle of diabetes. Nature 2003;423:599-602.
26. Juge-Aubry CE, Somn E, Chicheportiche R, et al. Regulatory effects of interleukin (IL)-1, interferon-β, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. J Clin Endocrinol Metab 2004;89:2652-2658.
27. Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 1996;271:665-668.
28. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
29. Doxey DL, Cutler CW, Iacopino AM. Diabetes prevents periodontitis-induced increases in gingival platelet derived growth factor-B and interleukin 1-beta in a rat model. J Periodontol 1998;69: 113-119.
30. Zykova SN, Jensen TG, Berdal M, Olsen R, Myklebust R, Seljelid R. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000;49:1451-1458.
31. Garcia-Welsh A, Schneiderman JS, Baly DL. Interleukin-1 stimulates glucose transport in rat adipose cells. Evidence for receptor discrimination between IL-1β and IL-1α. FEBS Lett 1990; 269:421-424.
32. Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acids-induced insulin resistance is associated with activation of protein C theta and alterations in the insulin signaling cascade. Diabetes 1999;48:1270-1274.